Viewing Study NCT01240720


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-06-25 @ 1:08 AM
Study NCT ID: NCT01240720
Status: COMPLETED
Last Update Posted: 2014-02-25
First Post: 2010-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer
Sponsor: Philogen S.p.A.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None I131 View
None F16 View
None antibody View
None monoclonal View
None tumor targeting View
None radioimmunotherapy View
None lymphoma, breast and lung cancer View
None Patients with different cancer types View